The study revealed the risk of developing venous thromboembolisms from various types of synthetic hormones, providing ...

Although Stelara and Entyvio demonstrated similar cardiovascular safety profiles among older patients with inflammatory bowel ...

A systematic review and meta-analysis estimating the differences in bleeding risks between therapeutic-dose non-vitamin K oral anticoagulants (NOACs) and single antiplatelet therapy (aspirin) found ...

Venous thromboembolism (VTE) risk varies across hormonal contraceptives, according to a research letter published online Feb.

Biologic medicines have transformed treatment for numerous chronic and life-threatening conditions such as cancer, ...

Doctors at Queen Mary University of London, Barts Health NHS Trust, and University College London have led the development of ...

However, clinical practice guidelines do not specifically address the issue of VTE prophylaxis in patients with cirrhosis and elevated INR values. There are limited data on the risk of VTE in ...

The clot-dissolving medication, alteplase, improved stroke patients' recovery by more than 50% when given up to 24 hours after the beginning of an ischemic stroke, according to preliminary ...

Below we have compiled a full list of Google algorithm launches, updates, and refreshes that have rolled out over the years, as well as links to resources for SEO professionals who want to ...

Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery ...

SINGAPORE – Guidelines to manage the use of screens among young children have been updated by the Ministry of Health, to provide stricter and clearer advice for parents. This is part of a newly ...

Cerebral venous sinus lesions, such as venous sinus stenosis, diverticula, and high-riding jugular bulb, are uncommon causes of PT, for which there is no standard treatment. Endovascular interventions ...